Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Siegfried
Siegfried
Activities:
Manufacturing
Ingredients
Regulatory
Research & Development
Cleaning
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Swiss biomanufacturing sector continues to thrive in 2023
Seigfried, Lonza, ten23 health, Bachem and Dottikon all announce major expansions
Manufacturing
DiNAQOR agrees acquisition to commercialise CGT development and manufacturing platform
Siegfried has made a total investment for the majority acquisition of CDMO DiNAMIQS and the establishment of the new GMP facility that will be in the mid-double-digit millions Swiss Francs
You need to be a subscriber to read this article.
Click here
to find out more.
Manufacturing
Optimising scale-up with flow process technologies
Speed of synthesis is of the essence when medicinal chemists invent new molecules, reports Sarah Houlton
Design & Build
Siegfried acquires three BASF sites
Acquisition represents the final step in Siegfried’s targeted 5-year procurement policy
Media
Siegfried Group sells biologics division
<p>The Siegfried Group, based in Zofingen in Switzerland, is selling its biotechnology business unit to an Indian company, Avesta Biotherapeutics and Research (ABRPL), for an undisclosed sum. </p>
Sharp increase in profits at Siegfried Group
Swiss pharmaceutical company The Siegfried Group has reported its best financial results in its 130-year history.
Subscribe now